Gels: Clinical Trials

51 trials of Gels, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 3 unknown, 3 withdrawn, 1 active not recruiting. 51 Phase 1, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 151Completed 41, Unknown 3, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 212Completed 8, Unknown 3, Withdrawn 1

Follow Gels: new trials by email Literature Review of Gels trials Research Report on Gels

Trials (filtered) newest first · largest first

All 51 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photodynamic Therapy For Onychomycosis
ALA 10% gel, PDT, Urea - Onychomycosis of Toenail
Phase 1Active not recruitingThe University of Texas Health Science Center, Houston52026-08-102026-10-06
Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity
Potassium nitrate and sodium fluoride, Cannabidiol (CBD) Gel, Natrosol 4% Gel - Dentin Sensitivity
Phase 1Not yet recruitingUniversidade Federal do Para752025-07-252025-06-18
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment - Atopic Dermatitis
Phase 1RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)862025-05-222026-07-02
Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.
Diclofenac sodium gel, Diclofenac diethylamine 1.16% gel - Healthy Volunteer
Phase 1CompletedAmzell342024-11-292026-01-06
Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis
Aloe vera gel, Benzydamine Hydrochloride 0.15% Oral gel, bioadhesive gel - Radiation Indused Oral Mucositis
Phase 1 / Phase 2CompletedMinia University302023-11-012025-03-06
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
PTW-002 10 mg/g gel, Placebo - Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2UnknownPhoenicis Therapeutics82023-04-302023-03-31
NPC-12G Gel 0.2% Sirolimus PK Bridging Study
NPC-12G Gel 0.2%, Rapamune® 2 mg tablet - Bioavailability Study
Phase 1CompletedNobelpharma122019-05-312020-03-06
Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
Vehicle Gel Base, Imiquimod 5% gel, Imiquimod 0,05% gel - Actinic Cheilitis
Phase 1TerminatedHospital de Clinicas de Porto Alegre492019-03-232022-11-22
Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia
Topical lidocaine 2% jelly plus sub-tenon ropivacaine 10% injection, Peribulbar injection - Retinal Disease, Diabetic Retinopathy
Phase 1 / Phase 2CompletedUniversity of Sao Paulo562019-01-012019-11-04
A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty
Diclofenac Diethylamine (DDEA) gel, Placebo gel - Pain
Phase 1CompletedGlaxoSmithKline472018-07-192020-02-24
Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer
gel combined with lemongrass (Cymbopogon citratus) oil at 0.1% concentration, Collagenase ointment, Gel with 10% peel powder of unripe banana - Chronic Ulcer, Healing Ulcer
Phase 1CompletedUniversidade do Vale do Sapucai252018-02-022021-07-15
A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients
TR-399 (5% Vardenafil HCl·3H2O, topical gel) - Erectile Dysfunction
Phase 1 / Phase 2UnknownTritech Biopharmaceuticals Co., Ltd.262017-03-312017-11-22
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
Azelaic Acid 15% topical gel, Finacea® (azelaic acid) Gel, 15%, Placebo - Rosacea
Phase 1CompletedSun Pharmaceutical Industries, Inc.10002016-07-012024-04-10
Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel
IDP-120 Gel - Acne
Phase 1CompletedBausch Health Americas, Inc.202016-06-012017-09-25
Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
ingenol mebutate 0.05% gel - Verruca Vulgaris, Common Warts
Phase 1CompletedNeal D. Bhatia, MD162016-04-272017-07-17
Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults
Maraviroc 300 mg tablet (PO) and Maraviroc 1% gel (PR and PV) - HIV/AIDS
Phase 1CompletedInternational Partnership for Microbicides, Inc.192015-01-012017-09-08
MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers
Jelly with:Paracetamol, Jelly with Furosemide, Jelly with Levothyroxine sodium salt - Healthy
Phase 1CompletedCentre Hospitalier Universitaire de Nice162014-06-012015-10-07
Safety and Efficacy of PG101 for Dry Eye Syndrome
PG101 - Dry Eye Syndrome
Phase 1 / Phase 2CompletedRhodes Pharmaceuticals, L.P.722013-12-012014-03-05
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Tenofovir 1% gel, Vaginal product - HIV Prevention
Phase 1CompletedCONRAD1012013-12-012015-05-22
Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure
Lidocaine 2% Gel - Other Preterm Infants
Phase 1CompletedMansoura University Children Hospital602013-10-012015-04-14

Showing 20 of 51. Sign in to see all of them.

Conditions studied

Acne Vulgaris (10)  ·  Pain (5)  ·  Keratosis, Actinic (3)  ·  Insulin Resistance (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Actinic cheilitis (1)  ·  Altitude Sickness (1)  ·  Dentin Sensitivity (1)  ·  Dermatitis, Atopic (1)  ·  Dermatitis, Phototoxic (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Retinopathy (1)  ·  Dry Eye Syndromes (1)  ·  Eczema (1)  ·  Epidermolysis Bullosa (1)

Sponsors

CONRAD (5)  ·  Allergan (3)  ·  Coria Laboratories, Ltd. (2)  ·  Dr. Reddy's Laboratories Limited (2)  ·  GlaxoSmithKline (2)  ·  Ian McGowan (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Novan, Inc. (2)  ·  Peplin (2)  ·  Pfizer (2)  ·  Sun Pharmaceutical Industries, Inc. (2)  ·  University of Washington (2)  ·  Amzell (1)  ·  Bausch Health Americas, Inc. (1)  ·  Centre Hospitalier Universitaire de Nice (1)

Countries

United States (26)  ·  Brazil (4)  ·  Canada (3)  ·  Egypt (2)  ·  France (2)  ·  Germany (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Chile (1)  ·  Dominican Republic (1)  ·  Peru (1)  ·  Puerto Rico (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Benoit Girard, MD (2)  ·  Ian McGowan, MD, PhD, FRCP (2)  ·  Jonothan S Dosik, MD (2)  ·  Stephanie T Page, MD, PhD (2)  ·  Abdias Hurtado, MD (1)  ·  Alex Carballo-Dieguez, PhD (1)  ·  Anya Loncaric (1)  ·  Craig Hendrix, MD (1)  ·  Donald Leung, MD, PhD (1)

Results publications

PMID 24765228, PMID 17342504, PMID 21177791, PMID 23573238, PMID 23842718, PMID 25647729, PMID 25942472, PMID 26227279, PMID 27362788, PMID 27482750, PMID 29793828, PMID 34384282, PMID 39147219, PMID 41869811

NIH funding

U01AI068633 (2), U19AI082637 (2), K23AG027238 (1)